4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0000899243-22-023978
Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowden Christopher Director | 2022-06-22 | Grant or award | +40,000 | 44,167 | D | ||
| Derivatives | |||||||
| Bowden Christopher Director | 2022-06-22 | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X03/doc4.xml…